Market Analysis — ST. JAMES HOSPITAL
NY market | 3 hospitals | HHI: 5,664 (Concentrated)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
3
Hospitals in Market
95
Total Beds
$0.2B
Market Revenue
Concentrated
HHI: 5,664
None
Moat Rating (4/10)
#2
Market Share Rank
Competitive Moat (Mauboussin Framework)
Based on "Measuring the Moat" adapted for healthcare. Score 0-10: wide (8+), narrow (5-7), none (<5).
Scale Advantageweak
Switching Costslow
Market Share19.7%
Top 3 Concentration100.0%
Network Density3.00
Margin vs Market+22.4%
Bed Util vs Market+23.8%
What This Means
This hospital has a none moat — no moat — commoditized market position, pricing power limited. The NY market is highly concentrated — few dominant players, potential antitrust concerns (HHI: 5,664).
Implications: Operational improvements are the primary value driver — see the EBITDA bridge. Compare against peers via comparables or see the full NY market.
Top Competitors
| Hospital | Beds | Revenue | Rev Share | Bed Share |
|---|---|---|---|---|
| CORNING HOSPITAL | 65 | $169M | 72.2% | 68.4% |
| IRA DAVENPORT MEMORIAL HOSPITAL INC | 15 | $19M | 8.1% | 15.8% |
Regional Payer Mix
■ Medicare 31%■ Medicaid 2%■ Commercial 67%